Lv1
52 积分 2023-07-11 加入
Uncovering the hidden landscape of tumour antigens
1天前
求助中
Investigation of the enhanced antitumour potency of CD46-specific chimeric antigen receptor-T cells in human colorectal cancer liver metastases after combination with nanotherapeutics
17天前
已完结
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer
23天前
已完结
Adenovirus type 11 binding alters the conformation of its receptor CD46
27天前
已完结
Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors
28天前
已完结
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers
1个月前
已完结
Comprehensive analysis of EphA2 in pan‐cancer: A prognostic biomarker associated with cancer immunity
1个月前
已完结
Apical–basal polarity and the control of epithelial form and function
1个月前
已完结
Multiscale photocatalytic proximity labeling reveals cell surface neighbors on and between cells
2个月前
已完结
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer
2个月前
已完结
皖公网安备34019202002308
